Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan
  • USA - English


News provided by

Frost & Sullivan

03 Mar, 2025, 18:30 IST

Share this article

Share toX

Share this article

Share toX

Leading the Way in Healthcare Innovation Across the Medication Journey

SAN ANTONIO, March 3, 2025 /PRNewswire/ -- DrFirst, a leading innovator in healthcare technology, has been honored with the prestigious Enabling Technology Leadership Award by Frost & Sullivan. This recognition highlights how the outstanding contributions of DrFirst bridge critical gaps in healthcare through groundbreaking technology solutions. With its comprehensive platform, DrFirst optimizes the medication journey from prescribing to adherence, with integrated solutions that directly address critical challenges in prescription management and orchestration; medication access, affordability, and adherence; and clinical data accuracy.

The U.S. healthcare market has long struggled with entrenched resistance to change, resulting in isolated healthcare information systems that hinder collaboration. Limited interoperability has led to inefficiencies, medication errors, and unnecessary hospital readmissions. In response to these challenges, DrFirst has developed a holistic, technology-driven approach that empowers healthcare professionals and patients with real-time access to accurate patient information, enhancing decision-making and improving outcomes.

DrFirst has pioneered innovative solutions that integrate with electronic health records (EHRs), health information exchanges (HIEs), and pharmacy systems, simplifying workflows and transforming how providers, pharmacists, and other stakeholders collaborate for high-quality patient care.

Key achievements that contributed to this award include:

  • Prescription Orchestration Technology — The company's latest innovation reinvents how ePrescriptions are shared between providers, pharmacies, and payers, enabling clinical collaboration and custom workflows that speed access to specialty medications.

  • AI-Powered Solutions — Using artificial intelligence and real-time data sharing, DrFirst innovations minimize prescription errors and boost clinical workflow efficiency.

  • Patient Engagement and Adherence — DrFirst digital tools empower patients with cost-saving and educational resources, prescription price transparency, and access to patient support, lowering prescription abandonment.

  • Medication Reconciliation Excellence — The company improves the accuracy of medication history, significantly reducing adverse drug events and hospital readmissions.

"Innovation is not just about technology—it's about empowering people," said G. Cameron Deemer, DrFirst CEO. "This recognition from Frost & Sullivan underscores our culture of innovation and commitment to eliminating friction in medication management for all stakeholders in healthcare, ultimately achieving better medication outcomes for everyone."

Through strategic partnerships with over 2,000 hospitals, 270 EHR systems, and 70,000 pharmacies, DrFirst solutions reach 100 million patients annually. The company's collaborative approach fosters a healthcare ecosystem where providers can make informed, timely decisions while mitigating costs and inefficiencies.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features, functionality, and rapidly growing market acceptance. The award recognizes the solution's quality and the customer value it delivers.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

About DrFirst
For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare workflows and help patients start and stay on therapy with end-to-end solutions that enhance prescription access, affordability, and adherence. DrFirst has recently won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions help 100 million patients a year and are used by more than 420,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit DrFirst.com and follow @DrFirst.

Contact:

Camila Tinajero
P: +54911 6713 2748
E: [email protected] 

Modal title

Also from this source

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology Innovation Leadership recognition in the Integrated ...

Frost & Sullivan: UFODRIVE Receives the 2025 European New Mobility and Automotive Technology Innovation Leadership Recognition for Enhancing Customer Impact through Digital Innovation

Frost & Sullivan is pleased to announce that UFODRIVE has received the 2025 European New Mobility and Automotive Technology Innovation Leadership...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

Computer Software

Computer Software

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.